Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CRDF stock hub

Cardiff Oncology, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRDFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

112.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRDF

In the news

Latest news · CRDF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-71.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-46.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRDF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

USD

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001213037
Company name	Cardiff Oncology, Inc.
Country	United States
Country code	US
Cusip	14147L108
Employees	31
Employees Change	-2%
Employees Change Percent	-6.06
Enterprise value	$54.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US14147L1089
Last refreshed	2026-05-10
Market cap	$112.1M
Market cap category	Micro-Cap
Price	$1.64
Price currency	USD
Rev Per Employee	19,129.03x
Sector	Healthcare
Sic	2836
Symbol	CRDF
Website	https://www.cardiffoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.91%
EV Sales Forward	152.37x
EV/Sales	92.17x
FCF yield	-33.86%
P/B ratio	2.47x
P/S ratio	189.08x
PS Forward	312.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-1.8M
Gross Profit Growth Q	9.71%
Net Income	$-45.9M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-7,732.04%
Profit Per Employee	$-1.5M
ROA	-38.47
Roa5y	-26.53
ROCE	-107.6
ROE	-71.45
Roe5y	-46.09
ROIC	-46.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-39.68%
Cagr15y	-22.96%
Cagr1y	-34.16%
Cagr20y	-26.55%
Cagr3y	-4.45%
Cagr5y	-29.61%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	-13.18x
Revenue Growth Q	60.93x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	15.39x
Revenue Growth5 Y	10.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$61.9M
Cash	$58.3M
Current Assets	$60.1M
Current Liabilities	$16.4M
Debt	$832,000
Debt Equity	$0.02
Equity	$45.4M
Liabilities	$16.5M
Long Term Assets	$1.8M
Long Term Liabilities	$102,000
Net Cash	$57.5M
Net Cash By Market Cap	$51.26
Net Cash Growth	-36.3%
Net Debt Equity	$-1.27
Tangible Book Value	$45.4M
Tangible Book Value Per Share	$0.66
WACC	11.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.67
Net Working Capital	$-13.8M
Quick ratio	3.59
Working Capital	$43.7M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.36%
1Y total return	-34.14%
200-day SMA	2.16
3Y total return	-12.77%
50-day SMA	1.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-82.72%
All Time High	2,030.4
All Time High Change	-99.92%
All Time High Date	2005-06-08
All Time Low	0.7
All Time Low Change	133.95%
All Time Low Date	2020-03-19
ATR	0.1
Beta	1.36
Beta1y	2.21
Beta2y	1.18
Ch YTD	-41.64
High	1.68
High52	4.56
High52 Date	2025-07-18
High52ch	-64%
Low	1.61
Low52	1.48
Low52 Date	2026-02-05
Low52ch	10.81%
Ma50ch	-5.64%
Premarket Change Percent	1.88
Premarket Price	$1.63
Premarket Volume	2,371
Price vs 200-day SMA	-23.97%
RSI	47.06
RSI Monthly	42.57
RSI Weekly	41.19
Sharpe ratio	-0.12x
Sortino ratio	-0.09
Total Return	-40.28%
Tr YTD	-41.64
Tr15y	-98%
Tr1m	5.13%
Tr1w	-4.09%
Tr3m	2.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$10
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.13
Earnings Revenue Estimate	90,000x
Earnings Revenue Estimate Growth	-17.43x
Operating Income	$-49M
Operating margin	-8,256.3
Price target	$9.63
Price Target Change	$487
Price Target Change Top	$510

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66,711,754%
Float Percent	97.57%
Shares Insiders	2.43%
Shares Institutions	37.72%
Shares Out	68,369,896
Shares Qo Q	0.83%
Shares Yo Y	40.28%
Short Float	27.46%
Short Ratio	26.86
Short Shares	26.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-43.7M
Average Volume	698,401.95x
Bv Per Share	0.66
CAPEX	$-44,000
Ch10y	-99.36
Ch15y	-98
Ch1m	5.13
Ch1w	-4.09
Ch1y	-34.14
Ch20y	-99.79
Ch3m	2.5
Ch3y	-12.77
Ch5y	-82.72
Ch6m	-25.11
Change	2.5%
Change From Open	1.86
Close	1.6
Days Gap	0.63
Depreciation Amortization	364,000
Dollar Volume	740,153.3
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-49M
EBITDA	$-48.6M
EPS	$-0.69
F Score	1
FCF	$-38M
FCF EV Yield	-69.47x
FCF Per Share	$-0.56
Financing CF	2,581,000
Fiscal Year End	December
Founded	1,999
Investing CF	1,342,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-24
Last Report Date	2025-12-31
Last Split Date	2019-02-20
Last Split Type	Reverse
Last10k Filing Date	2026-02-24
Ma150	2.1
Ma150ch	-21.76%
Ma20	1.68
Ma20ch	-2.38%
Net CF	-34,000,000
Next Earnings Date	2026-05-22
Open	1.61
Optionable	Yes
Position In Range	44.44
Post Close	1.64
Postmarket Change Percent	0.61
Postmarket Price	$1.65
Ppne	1,207,000
Pre Close	1.6
Price Date	2026-05-08
Ptbv Ratio	2.47
Relative Volume	0.65x
Revenue	593,000x
SBC By Revenue	960.03x
Share Based Comp	5,693,000
Tr20y	-99.79%
Tr6m	-25.11%
Us State	California
Volume	451,313
Z Score	-4.19

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRDF pay a dividend?

Capital-return profile for this ticker.

Performance

CRDF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRDF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+37.7%

Float: +97.6% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRDF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.1

Neutral momentum band

Price vs 200-day MA

-24.0%

50/200-day relationship not available

Beta (5Y)

1.36

More volatile than the market

Sharpe ratio

-0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRDF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRDF stock rating?

Cardiff Oncology, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRDF analysis?

The full report lives at /stocks/CRDF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRDF?

The latest report frames CRDF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRDF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.